Hematology & Oncology Doctors in Mayfield Hts, OH Accepting Medicare

3 Hematology & Oncology doctors found. Showing 1 - 3

Elliott Dickman, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 5885 Landerbrook Dr Ste 100, Mayfield Hts, OH 44124 Phone: 440-460-1616    Fax: 440-995-1908

Jason Stern, DO Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5885 Landerbrook Dr Ste 100, Mayfield Hts, OH 44124 Phone: 440-460-1616    Fax: 440-995-1908

Alan Lubin, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 730 Som Center Rd, Suite # 305, Mayfield Hts, OH 44143 Phone: 440-442-4260    Fax: 440-442-0249

News Archive

CTRC starts enrolment in Phase 2 combination trial of REOLYSIN and gemcitabine for advanced pancreatic cancer

Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center in San Antonio (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with gemcitabine (Gemzar(R)) in patients with advanced pancreatic cancer. The Principal Investigator is Dr. Monica Mita of the CTRC.

Three risk factors have the greatest impact on patient and graft survival rates for liver transplantation

Three risk factors: donor age; the length of time an organ is cooled between procurement and transplantation; and how urgently the recipient needs the transplant; have the greatest impact on patient and graft survival rates for liver transplantation, according to an article in the March issue of Archives of Surgery.

Clinical trial planned in Australia and the USA to help patients with ‘orphan' disease

Prana Biotechnology Limited announced today that researchers are planning recruitment for a phase II clinical trial of the experimental drug PBT2 in Huntington's patients. There are currently no treatments for the genetic, neurodegenerative disease; Australia is increasingly seen as a leader in the development of therapies for neurologic disorders. Huntington's often affects young adults and progressively impacts the body, mind and emotions. The disease causes incapacitation and death about 15-25 years after onset.

Vestibular thresholds begin to increase above age 40, new study finds

A new study led by researchers at Massachusetts Eye and Ear found that vestibular thresholds begin to double every 10 years above the age of 40, representing a decline in our ability to receive sensory information about motion, balance and spatial orientation.

Women with sexual trauma from childhood gain strength in self-help groups

Violence against women is a public health problem globally. Knowledge within the health care system about abuse in childhood as a possible cause of illness is limited, and this can lead to misdiagnoses.

Read more Medical News

› Verified 3 days ago